A detailed history of Thrivent Financial For Lutherans transactions in Becton Dickinson & CO stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 13,095 shares of BDX stock, worth $2.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,095
Previous 13,806 5.15%
Holding current value
$2.99 Million
Previous $3.23 Million 2.14%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$221.47 - $242.41 $157,465 - $172,353
-711 Reduced 5.15%
13,095 $3.16 Million
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $335,354 - $366,793
1,490 Added 12.1%
13,806 $3.23 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $257,962 - $273,741
-1,105 Reduced 8.23%
12,316 $3.05 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $26,707 - $30,731
-115 Reduced 0.85%
13,421 $3.27 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $38,999 - $43,389
153 Added 1.14%
13,536 $3.5 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $160,198 - $178,295
672 Added 5.29%
13,383 $3.53 Million
Q1 2023

May 17, 2023

SELL
$229.71 - $259.35 $52,373 - $59,131
-228 Reduced 1.76%
12,711 $3.15 Million
Q4 2022

Feb 08, 2023

BUY
$218.29 - $256.91 $54,354 - $63,970
249 Added 1.96%
12,939 $3.29 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $6.85 Million - $35.5 Million
-134,273 Reduced 91.37%
12,690 $2.83 Million
Q2 2022

Aug 16, 2022

SELL
$234.74 - $275.42 $11.1 Million - $13 Million
-47,365 Reduced 24.37%
146,963 $36.2 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $29.2 Million - $32.4 Million
119,837 Added 160.87%
194,328 $51.7 Million
Q4 2021

Feb 16, 2022

SELL
$230.08 - $250.94 $6.71 Million - $7.31 Million
-29,147 Reduced 28.12%
74,491 $18.7 Million
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $8.09 Million - $8.92 Million
34,776 Added 50.5%
103,638 $25.5 Million
Q2 2021

Aug 19, 2021

SELL
$232.65 - $254.58 $27.3 Million - $29.9 Million
-117,516 Reduced 63.05%
68,862 $16.7 Million
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $2.16 Million - $2.39 Million
9,307 Added 5.26%
186,378 $45.3 Million
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $1.49 Million - $1.66 Million
-6,730 Reduced 3.66%
177,071 $44.3 Million
Q3 2020

Nov 10, 2020

BUY
$215.77 - $276.76 $19.3 Million - $24.8 Million
89,553 Added 95.02%
183,801 $42.8 Million
Q2 2020

Aug 12, 2020

BUY
$219.9 - $263.41 $4.08 Million - $4.88 Million
18,545 Added 24.5%
94,248 $22.4 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $6.48 Million - $9.24 Million
-33,109 Reduced 30.43%
75,703 $17.4 Million
Q4 2019

Feb 13, 2020

BUY
$236.45 - $266.82 $12.6 Million - $14.2 Million
53,395 Added 96.35%
108,812 $29.6 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $6.58 Million - $7.31 Million
28,555 Added 106.3%
55,417 $14 Million
Q2 2019

Aug 13, 2019

SELL
$217.4 - $246.08 $73.3 Million - $83 Million
-337,144 Reduced 92.62%
26,862 $6.77 Million
Q1 2019

May 14, 2019

BUY
$206.05 - $248.17 $300,214 - $361,583
1,457 Added 0.4%
364,006 $90.9 Million
Q4 2018

Feb 15, 2019

BUY
$204.73 - $257.93 $24.6 Million - $30.9 Million
119,990 Added 49.47%
362,549 $81.7 Million
Q3 2018

Nov 15, 2018

BUY
$233.07 - $256.0 $53.7 Million - $58.9 Million
230,202 Added 1862.93%
242,559 $63.3 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $31,839 - $35,779
153 Added 1.25%
12,357 $2.96 Million
Q1 2018

May 08, 2018

BUY
$205.46 - $240.27 $55,885 - $65,353
272 Added 2.28%
12,204 $2.65 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $331,128 - $390,065
1,752 Added 17.21%
11,932 $2.55 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $1.9 Million - $2.02 Million
10,180
10,180 $1.99 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.